Cinctive Capital Management’s Viridian Therapeutics VRDN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-26,541	Closed	-$604K	–	478
2024 Q3	$604K	Sell	26,541 -20,707	-44%	-$471K	0.03%	314
2024 Q2	$615K	Buy	47,248 +6,390	+16%	+$83.1K	0.03%	320
2024 Q1	$715K	Sell	40,858 -310	-0.8%	-$5.43K	0.03%	302
2023 Q4	$897K	Buy	+41,168	New	+$897K	0.06%	255